AD

4-[(4-Methyl-1-piperazinyl)methyl]-N-(6-methyl-5-{[4-(3-pyridinyl)-2-pyrimidinyl]amino}-3-pyridinyl)-3-(trifluoromethyl)benzamide methanesulfonate (1:1)(CAS: 895519-91-2)

4-[(4-Methyl-1-piperazinyl)methyl]-N-(6-methyl-5-{[4-(3-pyridinyl)-2-pyrimidinyl]amino}-3-pyridinyl)-3-(trifluoromethyl)benzamide methanesulfonate (1:1)
CAS Number

Related Products

Other Suppliers for 4-[(4-Methyl-1-piperazinyl)methyl]-N-(6-methyl-5-{[4-(3-pyridinyl)-2-pyrimidinyl]amino}-3-pyridinyl)-3-(trifluoromethyl)benzamide methanesulfonate (1:1)

Basic Information

Molecular Formula
C30H33F3N8O4S
Molecular Weight
658.71 g/mol

Chemical Identifiers

SMILES
CC1=C(C=C(C=N1)NC(=O)C2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O
InChIKey
ZSASDYCFROUKTJ-UHFFFAOYSA-N

Database References

MDL Number
MFCD28053502

FAQ

Regulatory guidelines for 4-[(4-Methyl-1-piperazinyl)methyl]-N-(6-methyl-5-{[4-(3-pyridinyl)-2-pyrimidinyl]amino}-3-pyridinyl)-3-(trifluoromethyl)benzamide methanesulfonate (1:1) (CAS: 895519-91-2) include GHS classification, REACH regulations, and FDA/EPA requirements. Under GHS, it is classified as a hazardous substance due to its potential for causing skin and eye irritation. REACH regulations require manufacturers and importers to register and manage the risks associated with its production and use. FDA and EPA regulations focus on its safety in pharmaceutical and environmental contexts.
There are alternative reagents and synthetic approaches for 4-[(4-Methyl-1-piperazinyl)methyl]-N-(6-methyl-5-{[4-(3-pyridinyl)-2-pyrimidinyl]amino}-3-pyridinyl)-3-(trifluoromethyl)benzamide methanesulfonate (1:1) (CAS: 895519-91-2). Common alternatives include using different piperazine derivatives or modifying the pyrimidine or pyridine substituents. Isomers or analogs such as 4-[(4-Methyl-1-piperazinyl)methyl]-N-(6-methyl-5-{[3-(3-pyridinyl)-2-pyrimidinyl]amino}-3-pyridinyl)-3-(trifluoromethyl)benzamide could be considered as alternatives in certain synthetic pathways.
The market and research trends for 4-[(4-Methyl-1-piperazinyl)methyl]-N-(6-methyl-5-{[4-(3-pyridinyl)-2-pyrimidinyl]amino}-3-pyridinyl)-3-(trifluoromethyl)benzamide methanesulfonate (1:1) (CAS: 895519-91-2) are driven by its potential applications in pharmaceuticals, particularly as an analgesic and anticonvulsant. Recent research focuses on its efficacy and safety profiles, leading to increased demand in clinical trials. Market trends indicate a growing interest in developing and optimizing derivatives to enhance these properties.
Waste containing 4-[(4-Methyl-1-piperazinyl)methyl]-N-(6-methyl-5-{[4-(3-pyridinyl)-2-pyrimidinyl]amino}-3-pyridinyl)-3-(trifluoromethyl)benzamide methanesulfonate (1:1) (CAS: 895519-91-2) should be collected and disposed of according to local regulations. Liquid waste should be neutralized and then incinerated or stored in secure, appropriately labeled containers. Professional waste disposal services are recommended to ensure compliance with environmental protection measures. Proper handling includes wearing appropriate personal protective equipment and following safety protocols to prevent exposure and environmental contamination.

Safety Notice

Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.

Always follow proper handling procedures

Contact Information

Contact Person

Li Manager

Email

caokunli@163.com